Biodesix (BDSX) Invested Capital: 2019-2025
Historic Invested Capital for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -$1.7 million.
- Biodesix's Invested Capital fell 106.18% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 106.18%. This contributed to the annual value of $20.9 million for FY2024, which is 21.03% down from last year.
- Per Biodesix's latest filing, its Invested Capital stood at -$1.7 million for Q3 2025, which was down 251.32% from $1.1 million recorded in Q2 2025.
- Over the past 5 years, Biodesix's Invested Capital peaked at $42.1 million during Q2 2024, and registered a low of -$1.7 million during Q3 2025.
- Its 3-year average for Invested Capital is $16.6 million, with a median of $16.3 million in 2023.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 456.26% in 2024, then tumbled by 106.18% in 2025.
- Biodesix's Invested Capital (Quarterly) stood at $37.5 million in 2021, then decreased by 17.45% to $30.9 million in 2022, then fell by 14.57% to $26.4 million in 2023, then decreased by 21.03% to $20.9 million in 2024, then plummeted by 106.18% to -$1.7 million in 2025.
- Its last three reported values are -$1.7 million in Q3 2025, $1.1 million for Q2 2025, and $11.1 million during Q1 2025.